2014
DOI: 10.1042/bj20131119
|View full text |Cite
|
Sign up to set email alerts
|

TIMP-1 modulates chemotaxis of human neural stem cells through CD63 and integrin signalling

Abstract: We recently reported that hNSCs (human neural stem cells) have the interesting characteristic of migration towards an intracranial glioma. However, the molecules and mechanisms responsible for tumour tropism are unclear. In the present study, we used microarray and proteomics analyses to identify a novel chemoattractant molecule, TIMP-1 (tissue inhibitor of metalloproteinase-1), secreted from human brain tumour tissues. We demonstrate that TIMP-1 significantly enhances hNSC adhesion and migration in a cell cul… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
34
0
1

Year Published

2015
2015
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 47 publications
(37 citation statements)
references
References 59 publications
2
34
0
1
Order By: Relevance
“…Timp1 protein product is a metalloproteinase inhibitor known to be involved in cell adhesion and migration of human neural stem cells (hNSCs). In fact, through its cell surface receptor CD63, TIMP-1 activates β1 integrin, FAK (focal adhesion kinase) and the PI3K (phosphoinositide 3-kinase) signal transduction pathway, resulting in the migration of hNSCs (Lee et al, 2014). Due to its chemoattractant properties, TIMP-1 has been identified in the same study as a therapeutic target for human glioma.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Timp1 protein product is a metalloproteinase inhibitor known to be involved in cell adhesion and migration of human neural stem cells (hNSCs). In fact, through its cell surface receptor CD63, TIMP-1 activates β1 integrin, FAK (focal adhesion kinase) and the PI3K (phosphoinositide 3-kinase) signal transduction pathway, resulting in the migration of hNSCs (Lee et al, 2014). Due to its chemoattractant properties, TIMP-1 has been identified in the same study as a therapeutic target for human glioma.…”
Section: Resultsmentioning
confidence: 99%
“…Its signal trasduction pathway results in the migration of hNSCs, showing chemoattractant properties and being identified in the same study as a therapeutic target for human glioma (Lee et al, 2014). Here we suggest the same prospective use of Timp1 in MB Shh-type.…”
Section: Resultsmentioning
confidence: 99%
“…MMP-independent pathways can occur through TIMP-1 interaction with the cell surface tetraspanin CD63/integrin complex, which initiates PI3K/Akt-dependent pro-survival signaling [163, 291-293]. Interestingly, immunoprecipitation studies have demonstrated that mutated TIMP1, which lacks MMP inhibitory function, binds CD63 to a higher degree when compared to wild type protein [294].…”
Section: Rns-derived Signaling In Cancermentioning
confidence: 99%
“…TNF-α promotes survival of human quiescent bone marrow-derived CD34 + Burst Forming Unit-Erythrocyte (BFU-E) and facilitates the clonal expansion of JAK2 V617F -positive cells in MPNs [26, 32]. TIMP-1, through receptor (CD63) binding, promotes cell survival, differentiation and migration; also, TIMP-1 displays cytokine-like features in the HSPC compartment [3335]. It was initially found to enhance the proliferation of erythroid cells [36]; also, we recently demonstrated that TIMP-1 increases the clonogenic efficiency of normal CB-derived progenitor cells [37].…”
Section: Introductionmentioning
confidence: 99%